Catalyst Wire Dossier Catalyst Wire Dossier

FavId

idiotype vaccine · Favrille
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FavId, covering 2009-09-30 to 2009-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma [Phase 2]

See pricing